Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation — VANTAGE

Symptomatic Severe Aortic Stenosis Clinical Trial

Official title:
VANTAGE Clinical Trial Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation

Status Recruiting

Clinical Trial Summary

Evaluation of TAVR using the NAVITOR valve in a Global Investigation.

Clinical Trial Description

The VANTAGE clinical trial will evaluate the safety and effectiveness of the Navitor valve in patients with severe, symptomatic aortic stenosis who are at intermediate or low risk of surgical mortality. This trial will also evaluate the safety and effectiveness of the Navitor valve in a valve-in-valve application. ;

Study Design

Related Conditions & MeSH terms

Aortic Valve Stenosis
Symptomatic Severe Aortic Stenosis

Clinical Trial Details

NCT number	NCT04788888
Study type	Interventional
Source	Abbott Medical Devices
Contact	Nadia Bouhdi
Phone	+32 479 94 10 37
Email	nadia.bouhdi@abbott.com
Status	Recruiting
Phase	N/A
Start date	June 13, 2021
Completion date	February 28, 2036

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04011722` - Portico NG Approval Study	N/A
Completed	`NCT03222141` - PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - High Risk and Nested Registry 7	N/A
Completed	`NCT01314313` - PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk	N/A
Completed	`NCT03724812` - FlexNav EU CE Mark Study	N/A
Active, not recruiting	`NCT03222128` - PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate	N/A